Serine/threonine kinase 33 is a protein that in humans is encoded by the STK33 gene.

STK33
Identifiers
AliasesSTK33, serine/threonine kinase 33
External IDsOMIM: 607670; MGI: 2152419; HomoloGene: 75307; GeneCards: STK33; OMA:STK33 - orthologs
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_054103
NM_001355145

RefSeq (protein)

NP_473444
NP_001342074

Location (UCSC)Chr 11: 8.39 – 8.59 MbChr 7: 108.88 – 109.04 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

STK33 was identified as a synthetic lethal gene in KRAS-dependent cell lines.[5]

STK33 has been considered as a target for reversible male contraceptives and the inhibitor CDD-2807 has been tested successfully in mice.[6]

References

edit
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000130413Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000031027Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ Spoonamore J, Weïwer M, Wei J, Guichard B, Ross NT, Masson K, et al. (2010). "Screen for Inhibitors of STK33 Kinase Activity". Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US). PMID 23658944.
  6. ^ "Drug causes reversible male contraception in mice". 10 June 2024.
edit